Matches in Wikidata for { <http://www.wikidata.org/entity/Q95277008> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q95277008 description "artículu científicu espublizáu en mayu de 2020" @default.
- Q95277008 description "im Mai 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q95277008 description "scientific article published on 19 May 2020" @default.
- Q95277008 description "wetenschappelijk artikel" @default.
- Q95277008 description "наукова стаття, опублікована 19 травня 2020" @default.
- Q95277008 name "Co-delivery of Dacarbazine and All-Trans Retinoic Acid (ATRA) Using Lipid Nanoformulations for Synergistic Antitumor Efficacy Against Malignant Melanoma" @default.
- Q95277008 name "Co-delivery of Dacarbazine and All-Trans Retinoic Acid (ATRA) Using Lipid Nanoformulations for Synergistic Antitumor Efficacy Against Malignant Melanoma" @default.
- Q95277008 type Item @default.
- Q95277008 label "Co-delivery of Dacarbazine and All-Trans Retinoic Acid (ATRA) Using Lipid Nanoformulations for Synergistic Antitumor Efficacy Against Malignant Melanoma" @default.
- Q95277008 label "Co-delivery of Dacarbazine and All-Trans Retinoic Acid (ATRA) Using Lipid Nanoformulations for Synergistic Antitumor Efficacy Against Malignant Melanoma" @default.
- Q95277008 prefLabel "Co-delivery of Dacarbazine and All-Trans Retinoic Acid (ATRA) Using Lipid Nanoformulations for Synergistic Antitumor Efficacy Against Malignant Melanoma" @default.
- Q95277008 prefLabel "Co-delivery of Dacarbazine and All-Trans Retinoic Acid (ATRA) Using Lipid Nanoformulations for Synergistic Antitumor Efficacy Against Malignant Melanoma" @default.
- Q95277008 P1433 Q95277008-2C28C421-3B43-420B-A03F-7E9D02C77C03 @default.
- Q95277008 P1476 Q95277008-B7B068F9-EC68-44B1-AE32-83185AE89DAD @default.
- Q95277008 P2093 Q95277008-29B3F960-AD16-40B3-B78B-9136C55F5CB0 @default.
- Q95277008 P2093 Q95277008-9737C04A-B88F-401C-B36A-0F432A71A107 @default.
- Q95277008 P304 Q95277008-99F751CA-4AB7-4315-BADC-BCB8455C7990 @default.
- Q95277008 P31 Q95277008-F774679C-B07E-4386-A164-7CA3CC4D98D2 @default.
- Q95277008 P356 Q95277008-48358D3D-BA7F-4BD5-ACD4-C4FEF7CAEA98 @default.
- Q95277008 P433 Q95277008-D0DF1EF9-AF46-4A2E-BCCD-8A5E49C153EC @default.
- Q95277008 P478 Q95277008-05B7800C-D631-4D38-9F76-988840E146EC @default.
- Q95277008 P577 Q95277008-C95E84C9-14C7-4EA1-91A3-030DD9B0BB7B @default.
- Q95277008 P698 Q95277008-74F26BEE-E003-4D59-B595-044F60B2543E @default.
- Q95277008 P921 Q95277008-60724A72-ED05-4813-9430-112307181DDD @default.
- Q95277008 P921 Q95277008-D848D1CD-1078-43EF-9425-D19514B81F11 @default.
- Q95277008 P932 Q95277008-E445E84E-62DF-4DEE-B6F0-00819122AB18 @default.
- Q95277008 P356 S11671-020-3293-3 @default.
- Q95277008 P698 32430641 @default.
- Q95277008 P1433 Q1956338 @default.
- Q95277008 P1476 "Co-delivery of Dacarbazine and All-Trans Retinoic Acid (ATRA) Using Lipid Nanoformulations for Synergistic Antitumor Efficacy Against Malignant Melanoma" @default.
- Q95277008 P2093 "Chenyang Li" @default.
- Q95277008 P2093 "Xiuping Han" @default.
- Q95277008 P304 "113" @default.
- Q95277008 P31 Q13442814 @default.
- Q95277008 P356 "10.1186/S11671-020-3293-3" @default.
- Q95277008 P433 "1" @default.
- Q95277008 P478 "15" @default.
- Q95277008 P577 "2020-05-19T00:00:00Z" @default.
- Q95277008 P698 "32430641" @default.
- Q95277008 P921 Q29417 @default.
- Q95277008 P921 Q416975 @default.
- Q95277008 P932 "7237551" @default.